EMMAC Life Sciences Group Novel Foods Application Validated in UK and EU

Europe’s largest vertically integrated medical cannabis company, EMMAC Life Sciences Group, has gained validation from both the UK Food Standards Agency and the EU Food Safety Authority for its dossier on nature-identical CBD as a Novel Food.  The UK FSA has included in its updated Public List a number of EMMAC’s CBD products that are […]

EMMAC Life Sciences Group Launches First Medical Cannabis Flower for UK Market

EMMAC, Europe’s largest independent medical cannabis company, has announced the launch of its first range of unlicensed medical cannabis flower products for the UK market.  Only weeks after Curaleaf Holdings had agreed to buy EMMAC, EMMAC has teamed up with Sapphire Medical Clinics to offer the high THC flower product on prescription for a limited […]

US Cannabis Giant Curaleaf Enters European Market by Acquisition of EMMAC

Curaleaf Holdings, the “world’s largest cannabis retailer”, has agreed to buy EMMAC Life Sciences Group, Europe’s largest independent cannabis company and thus enter the European Cannabis Market in anticipation of a more liberal approach to the drug on the continent. It is reported that Curaleaf, the leading US provider of consumer products in cannabis, has […]